Plain-English translation of NCT07745530 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is investigating a hidden connection between platelets (tiny blood cells that help with clotting) and HIV persistence in people taking antiretroviral therapy. Researchers want to understand why some patients—despite taking HIV medication successfully and having an undetectable viral load—still struggle to rebuild their immune system. By studying blood samples from different groups of treated patients, scientists hope to uncover how platelets may be involved in keeping HIV hidden in the body.
Even though modern HIV medications work very well at stopping the virus from multiplying, the virus can hide in certain cells and reservoirs in the body. Some patients recover their immune system strength with treatment, but others don't—and doctors don't fully understand why. This study exists to investigate whether platelets play a role in this puzzle, which could eventually lead to better treatments for people whose immune systems aren't bouncing back despite being on effective medication.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate a blood sample that researchers will analyze in the laboratory. The study compares blood samples from three groups: people whose immune systems have recovered well on treatment, people whose immune systems haven't recovered despite undetectable viral loads, and those with different degrees of immune recovery. Your blood sample helps researchers study platelets and understand why some patients don't experience full immune recovery even with successful HIV treatment.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
France